國立虎尾科技大學 |

Bioequivalence requirements in various global jurisdictions

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Bioequivalence requirements in various global jurisdictions/ edited by Isadore Kanfer.
其他作者:	Kanfer, Isadore.
出版者:	Cham :Springer Nature Switzerland : : 2025.,
面頁冊數:	xiii, 237 p. :ill. (chiefly color), digital ; : 24 cm.;
Contained By:	Springer Nature eBook
標題:	Pharmacology. -
電子資源:	https://doi.org/10.1007/978-3-031-76774-6
ISBN:	9783031767746

Bioequivalence requirements in various global jurisdictions
Bioequivalence requirements in various global jurisdictions[electronic resource] /edited by Isadore Kanfer. - Second edition. - Cham :Springer Nature Switzerland :2025. - xiii, 237 p. :ill. (chiefly color), digital ;24 cm. - AAPS advances in the pharmaceutical sciences series,v. 612210-738X ;. - AAPS advances in the pharmaceutical sciences series ;3..

Brazil -- Canada -- The European Union (EU) -- India -- Japan -- The United States of America -- World Health Organization (WHO).

An important objective of Bioequivalence Requirements in Various Global Jurisdictions is to attempt to gather current and updated information, collated in a single source, regarding the various bioequivalence and related requirements to satisfy the regulatory requirements for the market approval of multi-source (generic) drug products in various global jurisdictions. In view of the dynamic nature of regulatory requirements which are usually regularly updated, updating these requirements to remain current is an important necessity to provide such information to drug manufacturers, regulatory agencies, pharmaceutical scientists and related health organizations and governments around the world in the quest to harmonize regulatory requirements for the market approval of generic products. The revised volume includes updated information based on recent guidances and guidelines from the respective regulatory agencies as well as important trends and descriptions relating to innovative approaches for bioequivalence assessment.

ISBN: 9783031767746

Standard No.: 10.1007/978-3-031-76774-6doiSubjects--Topical Terms:

583819
Pharmacology.

LC Class. No.: RM301.45

Dewey Class. No.: 615.1

Bioequivalence requirements in various global jurisdictions
LDR:02290nam a2200349 a 4500 001 1161721
003 DE-He213
005 20250430130221.0
006 m d
007 cr nn 008maaau
008 251029s2025 sz s 0 eng d
020 $a 9783031767746 $q (electronic bk.)
020 $a 9783031767739 $q (paper)
024 7 $a 10.1007/978-3-031-76774-6 $2 doi
035 $a 978-3-031-76774-6
040 $a GP $c GP
041 0 $a eng
050 4 $a RM301.45
072 7 $a PSB $2 bicssc
072 7 $a SCI013040 $2 bisacsh
072 7 $a PNB $2 thema
082 0 4 $a 615.1 $2 23
090 $a RM301.45 $b .B615 2025
245 0 0 $a Bioequivalence requirements in various global jurisdictions $h [electronic resource] / $c edited by Isadore Kanfer.
250 $a Second edition.
260 $a Cham : $c 2025. $b Springer Nature Switzerland : $b Imprint: Springer,
300 $a xiii, 237 p. : $b ill. (chiefly color), digital ; $c 24 cm.
490 1 $a AAPS advances in the pharmaceutical sciences series, $x 2210-738X ; $v v. 61
505 0 $a Brazil -- Canada -- The European Union (EU) -- India -- Japan -- The United States of America -- World Health Organization (WHO).
520 $a An important objective of Bioequivalence Requirements in Various Global Jurisdictions is to attempt to gather current and updated information, collated in a single source, regarding the various bioequivalence and related requirements to satisfy the regulatory requirements for the market approval of multi-source (generic) drug products in various global jurisdictions. In view of the dynamic nature of regulatory requirements which are usually regularly updated, updating these requirements to remain current is an important necessity to provide such information to drug manufacturers, regulatory agencies, pharmaceutical scientists and related health organizations and governments around the world in the quest to harmonize regulatory requirements for the market approval of generic products. The revised volume includes updated information based on recent guidances and guidelines from the respective regulatory agencies as well as important trends and descriptions relating to innovative approaches for bioequivalence assessment.
650 2 4 $a Pharmacology. $3 583819
650 2 4 $a Drug Safety and Pharmacovigilance. $3 1064651
650 1 4 $a Pharmaceutics. $3 1366841
650 0 $a Drugs $x Therapeutic equivalency. $3 778156
700 1 $a Kanfer, Isadore. $3 583395
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
830 0 $a AAPS advances in the pharmaceutical sciences series ; $v 3. $3 889162
856 4 0 $u https://doi.org/10.1007/978-3-031-76774-6
950 $a Chemistry and Materials Science (SpringerNature-11644)